ID

43813

Description

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication; ODM derived from: https://clinicaltrials.gov/show/NCT00296972

Lien

https://clinicaltrials.gov/show/NCT00296972

Mots-clés

Versions (3)
  1. 02/02/2017 02/02/2017 -
  2. 03/02/2017 03/02/2017 -
  3. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Hepatitis C NCT00296972

Anglais

Eligibility Chronic Hepatitis C NCT00296972

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
hepatitis c genotype 1 infection·
Description

Hepatitis C virus genotype 1 Infection

Type de données

boolean

Alias
UMLS CUI [1,1]
C3532919
UMLS CUI [1,2]
C3714514
detectable plasma hcv-rna roche>1000copies/ml, >600iu/ml
Description

Hepatitis C RNA Detectable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0855840
UMLS CUI [1,2]
C3830527
chronic liver disease consistent with chc infection on a biopsy obtained within the past 24 months
Description

Chronic liver disease Consistent with Chronic Hepatitis C Biopsy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0341439
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C0524910
UMLS CUI [1,4]
C0005558
patients with cirrhosis or incomplete cirrhosis must have an abdominal ultrasound, ct scan, or mri scan without evidence of hepatocellular carcinoma and a serum afp <100 ng/ml within 2 months of randomization
Description

Liver Cirrhosis | Liver Cirrhosis Incomplete | Transabdominal Ultrasound | CT of abdomen | MRI scan - abdominal | Liver carcinoma Evidence of | Alpha one fetoprotein measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C0205257
UMLS CUI [3]
C2348813
UMLS CUI [4]
C0412620
UMLS CUI [5]
C3842374
UMLS CUI [6,1]
C2239176
UMLS CUI [6,2]
C0332120
UMLS CUI [7]
C0201539
patients with cd4 cell count ³ 350 cells /µl
Description

CD4 Count determination procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0243009
patients on stable highly active antiretroviral therapy (haart) for at least 12 weeks prior to baseline with the exception of patients receiving didanosine
Description

Highly Active Antiretroviral Therapy Stable | Didanosine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0887947
UMLS CUI [1,2]
C0205360
UMLS CUI [2]
C0012133
hiv-1 rna is < 5000 copies/ml
Description

Human immunodeficiency virus 1 RNA Measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0369499
UMLS CUI [1,2]
C0242485
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
ifn, pegylated interferons, viramidine, levovirin, or ribavirin therapy at any previous time
Description

Interferons | pegylated interferon alfa | ribavirin amidine | Ribavirin

Type de données

boolean

Alias
UMLS CUI [1]
C0021747
UMLS CUI [2]
C0907160
UMLS CUI [3]
C0073221
UMLS CUI [4]
C0035525
patients with evidence of active hepatitis b infection. ( presence of hbsag)
Description

Hepatitis B Evidence of | Hepatitis B Surface Antigens Present

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019163
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C0019168
UMLS CUI [2,2]
C0150312
history or evidence of decompensated liver disease and/or a child-pugh score > 5, bleeding from esophageal varices, hepatic malignancy
Description

Decompensated liver disease Evidence of | Child-Pugh Classification | Bleeding esophageal varices | Malignant neoplasm of liver

Type de données

boolean

Alias
UMLS CUI [1,1]
C4075847
UMLS CUI [1,2]
C0332120
UMLS CUI [2]
C4050412
UMLS CUI [3]
C0155789
UMLS CUI [4]
C0345904
abnormal bloodwork ie absolute neutrophil <1,hbg <110, platelets <70,creatinine <50
Description

Hematologic function Abnormal | Absolute neutrophil count | Hemoglobin measurement | Platelet Count measurement | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0205161
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0201976
Retour au début de la page

Similar models

Eligibility Chronic Hepatitis C NCT00296972

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C virus genotype 1 Infection
Item
hepatitis c genotype 1 infection·
boolean
C3532919 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
Hepatitis C RNA Detectable
Item
detectable plasma hcv-rna roche>1000copies/ml, >600iu/ml
boolean
C0855840 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
Chronic liver disease Consistent with Chronic Hepatitis C Biopsy
Item
chronic liver disease consistent with chc infection on a biopsy obtained within the past 24 months
boolean
C0341439 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
C0005558 (UMLS CUI [1,4])
Liver Cirrhosis | Liver Cirrhosis Incomplete | Transabdominal Ultrasound | CT of abdomen | MRI scan - abdominal | Liver carcinoma Evidence of | Alpha one fetoprotein measurement
Item
patients with cirrhosis or incomplete cirrhosis must have an abdominal ultrasound, ct scan, or mri scan without evidence of hepatocellular carcinoma and a serum afp <100 ng/ml within 2 months of randomization
boolean
C0023890 (UMLS CUI [1])
C0023890 (UMLS CUI [2,1])
C0205257 (UMLS CUI [2,2])
C2348813 (UMLS CUI [3])
C0412620 (UMLS CUI [4])
C3842374 (UMLS CUI [5])
C2239176 (UMLS CUI [6,1])
C0332120 (UMLS CUI [6,2])
C0201539 (UMLS CUI [7])
CD4 Count determination procedure
Item
patients with cd4 cell count ³ 350 cells /µl
boolean
C0243009 (UMLS CUI [1])
Highly Active Antiretroviral Therapy Stable | Didanosine
Item
patients on stable highly active antiretroviral therapy (haart) for at least 12 weeks prior to baseline with the exception of patients receiving didanosine
boolean
C0887947 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0012133 (UMLS CUI [2])
Human immunodeficiency virus 1 RNA Measurement
Item
hiv-1 rna is < 5000 copies/ml
boolean
C0369499 (UMLS CUI [1,1])
C0242485 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Interferons | pegylated interferon alfa | ribavirin amidine | Ribavirin
Item
ifn, pegylated interferons, viramidine, levovirin, or ribavirin therapy at any previous time
boolean
C0021747 (UMLS CUI [1])
C0907160 (UMLS CUI [2])
C0073221 (UMLS CUI [3])
C0035525 (UMLS CUI [4])
Hepatitis B Evidence of | Hepatitis B Surface Antigens Present
Item
patients with evidence of active hepatitis b infection. ( presence of hbsag)
boolean
C0019163 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0019168 (UMLS CUI [2,1])
C0150312 (UMLS CUI [2,2])
Decompensated liver disease Evidence of | Child-Pugh Classification | Bleeding esophageal varices | Malignant neoplasm of liver
Item
history or evidence of decompensated liver disease and/or a child-pugh score > 5, bleeding from esophageal varices, hepatic malignancy
boolean
C4075847 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C4050412 (UMLS CUI [2])
C0155789 (UMLS CUI [3])
C0345904 (UMLS CUI [4])
Hematologic function Abnormal | Absolute neutrophil count | Hemoglobin measurement | Platelet Count measurement | Creatinine measurement, serum
Item
abnormal bloodwork ie absolute neutrophil <1,hbg <110, platelets <70,creatinine <50
boolean
C0221130 (UMLS CUI [1,1])
C0205161 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial